IQV
Price
$278.19
Change
+$1.56 (+0.56%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
45.53B
5 days until earnings call
Intraday BUY SELL Signals
MOVE
Price
$8.07
Change
-$0.38 (-4.50%)
Updated
Oct 22 closing price
Capitalization
254.63M
22 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IQV vs MOVE

IQV vs MOVE Comparison Chart in %
View a ticker or compare two or three
VS
IQV vs. MOVE commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IQV is a StrongBuy and MOVE is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for IQV with price predictions
Oct 22, 2026

IQV in +3.91% Uptrend, growing for three consecutive days on October 22, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where IQV advanced for three days, in 187 of 302 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on IQV as a result. In 46 of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.

The Moving Average Convergence Divergence (MACD) for IQV just turned positive on October 21, 2026. Looking at past instances where IQV's MACD turned positive, the stock continued to rise in 26 of 42 cases over the following month. The odds of a continued upward trend are 62%.

The Aroon Indicator entered an Uptrend today. In 113 of 222 cases where IQV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 51%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IQV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.

IQV broke above its upper Bollinger Band on October 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 5 (best 1 - 100 worst), indicating outstanding price growth. IQV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 43 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.379) is normal, around the industry mean (66.046). P/E Ratio (34.068) is within average values for comparable stocks, (2.422). Projected Growth (PEG Ratio) (0.985) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.693) is also within normal values, averaging (9.775).

The Tickeron Profit vs. Risk Rating rating for this company is 90 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IQV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

A.I.Advisor
a Summary for MOVE with price predictions
Oct 22, 2026

Momentum Indicator for MOVE turns negative, indicating new downward trend

MOVE saw its Momentum Indicator move below the 0 level on October 06, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned negative. In 82 of the 91 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for MOVE turned negative on October 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 59 similar instances when the indicator turned negative. In 55 of the 59 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

MOVE moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MOVE crossed bearishly below the 50-day moving average on October 07, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MOVE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for MOVE entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for MOVE's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 62 of 68 cases where MOVE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.

Following a +6.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where MOVE advanced for three days, in 205 of 246 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

MOVE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-65.592) is normal, around the industry mean (15.867). P/E Ratio (-0.597) is within average values for comparable stocks, (56.069). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.212) among similar stocks. P/S Ratio (5.110) is also within normal values, averaging (103.889).

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. MOVE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MOVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

FUNDAMENTALS RATINGS
IQV: Fundamental Ratings
IQV
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
43
PRICE GROWTH RATING
1..100
5
P/E GROWTH RATING
1..100
31
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IQVMOVE
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
61%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
62%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
63%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
64%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
51%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (IQV: $276.63 vs. MOVE: $8.45)
Brand notoriety: IQV: Notable vs. MOVE: Not notable
IQV represents the Medical Specialties, while MOVE is part of the Computer Communications industry
Current volume relative to the 65-day Moving Average: IQV: 121% vs. MOVE: 23%
Market capitalization -- IQV: $45.53B vs. MOVE: $254.63M
IQV [@Medical Specialties] is valued at $45.53B. MOVE’s [@Computer Communications] market capitalization is $254.63M. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The market cap for tickers in the [@Computer Communications] industry ranges from $48.8K to $3.87T. The average market capitalization across the [@Medical Specialties] industry is $20.94B. The average market capitalization across the [@Computer Communications] industry is $36.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IQV’s FA Score shows that 2 FA rating(s) are green while MOVE’s FA Score has 2 green FA rating(s).

  • IQV’s FA Score: 2 green, 3 red.
  • MOVE’s FA Score: 2 green, 3 red.
According to our system of comparison, IQV is a better buy in the long-term than MOVE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IQV’s TA Score shows that 4 TA indicator(s) are bullish while MOVE’s TA Score has 4 bullish TA indicator(s).

  • IQV’s TA Score: 4 bullish, 3 bearish.
  • MOVE’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, IQV is a better buy in the short-term than MOVE.

Price Growth

IQV (@Medical Specialties) experienced а +5.58% price change this week, while MOVE (@Computer Communications) price change was -4.95% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.15%. For the same industry, the average monthly price growth was -6.50%, and the average quarterly price growth was +42.74%.

The average weekly price growth across all stocks in the @Computer Communications industry was -1.36%. For the same industry, the average monthly price growth was -9.84%, and the average quarterly price growth was +4.51%.

Reported Earning Dates

IQV is expected to report earnings on Oct 27, 2026.

MOVE is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Medical Specialties (-3.15% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Computer Communications (-1.36% weekly)

Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.

View a ticker or compare two or three
IQV
Daily Signal:
Gain/Loss:
MOVE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

IQV and

Correlation & Price change

A.I.dvisor indicates that over the last year, IQV has been closely correlated with CRL. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IQV
1D Price
Change %
IQV100%
+0.61%
CRL - IQV
71%
Closely correlated
-1.51%
TMO - IQV
68%
Closely correlated
-2.52%
RVTY - IQV
59%
Loosely correlated
+0.48%
A - IQV
58%
Loosely correlated
-2.17%
ICLR - IQV
54%
Loosely correlated
+0.10%
More

MOVE and

Correlation & Price change

A.I.dvisor tells us that MOVE and BNAI have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MOVE and BNAI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MOVE
1D Price
Change %
MOVE100%
-4.50%
BNAI - MOVE
29%
Poorly correlated
-7.38%
CRL - MOVE
25%
Poorly correlated
-1.51%
LIVN - MOVE
25%
Poorly correlated
+3.61%
IQV - MOVE
25%
Poorly correlated
+0.61%
BFLY - MOVE
24%
Poorly correlated
-4.08%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYA2.87-0.01
-0.35%
SkyAI Inc.
OVV69.30-0.56
-0.80%
Ovintiv
RZLV1.48-0.13
-8.07%
Rezolve AI PLC
BELFB199.81-20.74
-9.40%
Bel Fuse
SNTI0.19-0.03
-12.41%
Senti Biosciences Holdings Inc.